Barclays Retains an Equal Weight Rating on Acadia Healthcare Company, Inc. (ACHC)

March 10, 2026 - 09:58

Barclays analyst Andrew Mok has reaffirmed an Equal Weight rating on Acadia Healthcare Company, Inc. (ACHC) while significantly raising the firm's price target. The new target of $20, up from $14, was issued on March 2, 2026. This move follows a period of strong performance for the behavioral healthcare provider's stock, which ranked among the twelve best performers on the NASDAQ in February.

The revised valuation comes shortly after the company released its fourth-quarter 2025 financial results. Acadia reported quarterly revenue of $821.5 million, providing investors with a key operational update. The analyst's decision to maintain a neutral Equal Weight rating suggests a balanced view, acknowledging positive momentum while potentially awaiting further evidence of sustained growth or execution on strategic plans.

The substantial increase in the price target reflects a more optimistic assessment of the company's financial outlook or market position. Such adjustments are closely watched by investors as indicators of institutional sentiment regarding a stock's future trajectory. The healthcare sector, particularly in behavioral services, continues to be a focal point for market participants given evolving demand and regulatory landscapes. Acadia Healthcare's recent stock strength and this analyst action highlight its prominent position within the industry.